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Abstract 
Background: Cox proportional hazard model (CPH) is commonly used in clinical research for 
survival analysis. In quantitative medical imaging (radiomics) studies, CPH plays an important 
role in feature reduction and modeling. However, the underlying linear assumption of CPH 
model limits the prognostic performance. In addition, the multicollinearity of radiomic features 
and multiple testing problem further impedes the CPH models performance. In this work, using 
transfer learning, a convolutional neural network (CNN) based survival model was built and 
tested on preoperative CT images of resectable Pancreatic Ductal Adenocarcinoma (PDAC) 
patients.  
Results: The proposed CNN-based survival model outperformed the traditional CPH-based 
radiomics approach in terms of concordance index by 22%, providing a better fit for patients’ 
survival patterns.  
Conclusions: The proposed CNN-based survival model outperforms CPH-based radiomics 
pipeline in PDAC prognosis. This approach offers a better fit for survival patterns based on CT 
images and overcomes the limitations of conventional survival models. 
Keywords: Cox proportional hazard model, radiomics, convolutional neural network, survial 
analysis 
 
 
Background 
As a statistical method, survival analysis is commonly used in clinical research to identify potential 
risk factors or biomarkers for a variety of clinical outcomes including patients’ overall survivals for 
different diseases such as cancer. Cox proportional hazard model (CPH) is one of the most 
commonly used survival analysis tools1–4. CPH is a type of semiparametric model that calculates 
the effects of features (independent variables) on the risk of a certain event (e.g., death)5. For 
example, CPH can measure the effect of tumor size on the risk of death.  
The CPH-based survival models can help clinicians make more personalized treatment decisions 
for individual patients. CPH models assume that the independent variables make a linear 
contribution to the model, with respect to time5. In many conditions, this assumption oversimplifies 
the relationships between biomarkers and outcomes, especially in cancer diseases with poor 
prognosis including Pancreatic Ductal Adenocarcinoma (PDAC)3. With a limited sample size, the 
violation of linear assumption may not be obvious. However, as data sizes increase, the violation 
of linear assumption in CPH models increasingly becomes more obvious and problematic, 
diminishing the performance and reliability of such models2–4. 
In real-world cases, nonlinear risk models can often provide a better fit for a survival function3,6. 
There are mainly two types of non-linear survival models: classification methods and risk-
prediction methods2–4. Classification methods solve the nonlinearity by using a classifier such as 
Random Forest or Support Vector Machine (SVM)7,8. Although these classifiers perform well in 
many scenarios by providing binary predictions, they discard the duration information in modeling. 
For disease with poor prognosis such as pancreatic cancer, the 5-year survival rate is very low (e.g., 
less than 10% for pancreatic cancer)9–11. Consequently, binary predictions only offer limited 
information for healthcare professionals in designing personalized treatment plans and hence, a 
nonlinear survival model that takes duration (time to an event such as death) into account to provide 
useful information on the survival is desired. 
Risk-prediction models which are based on artificial neural networks (ANNs) learn complex and 
nonlinear relationships between prognostic features and an individual’s risk for a given outcome. 
Therefore, the ANNs-based model can provide an improved personalized recommendation based 
on the computed risk. Nevertheless, previous studies have demonstrated mixed performance for 
risk-prediction models6,12,13. This may be due to the small sample size and limited feature space 
leading to ANNs models that are underfitted6. To exploit the ANNs architecture and successfully 
apply them to complex cases, larger datasets are required. Recent work has shown that, given 
enough sample sizes, ANNs can, in fact, outperforms traditional CPH survival models2–4.  
In medical imaging, researchers have been working to extract diagnostic or prognostic features from 
medical images in different modalities14–19. Efforts have been made to standardize these quantitative 
imaging features (radiomic) by implementing open source libraries such as PyRadiomics20. These 
feature banks contain thousands of hand-crafted formulas, designed to extract the distribution or 
texture information. Subsequently, these features are often tested by CPH models selecting 
significant features and building the final survival model21,22. However, the high dimensionality 
nature of radiomics features introduces serious issues in feature reductions and prognosis 
performance through CPH models.  
Through a standard radiomics feature bank, more than 1000 features can be extracted from each 
ROI. Given the high dimensionality of features, multiple testing in CPH models becomes a 
challenge14. In addition, the proposed feature sets are often highly correlated due to the similarity 
of formulas16. Despite the linear assumption in CPH modeling, the multicollinearity in the feature 
space further impedes the performance. The limitations of the handcrafted radiomic features and 
the fact that ANNs outperform traditional CPH models, motivate designing a novel approach for 
survival modeling that combines CPH with state-of-the-art deep learning algorithms for improved 
performance. 
Previous work on deep learning based survival analysis including DeepSurv and NNET-survival 
are all ANNs-based survival models with modified loss function to capture more accurate survival 
patterns2,3. These models take features (e.g., age, gender, height) as input and return risks for 
patients at different timepoints. However, as discussed above, feeding radiomics features into these 
ANNs as input is not the optimal solution due to the multicollinearity issue. In this research, we use 
medical images as input, replacing conventional feature extractors with a Convolutional Neural 
Network (CNN) architecture to extract disease-specific image features which are associated with 
survival patterns. As the most well-known architecture in deep learning, CNNs extract imaging 
features by applying multiple layers of convolution operations to the images. Furthermore, the 
weights of the convolution filters are finetuned during training via backpropagation process23,24. 
Thus, given sufficient data, CNNs can be used to extract imaging features that are disease-specific, 
which can be used for diagnosis or prognosis purposes25–28. Although traditional medical imaging 
based CNNs use “binary” or “multinomial” classification loss function, the loss function can be 
modified to also capture the survival patterns3. By doing so, CNN can be tuned to extract features 
that are associated with the risk of the outcome in a certain duration. We hypothesized that CNNs 
would extract more meaningful features and the proposed CNN-based Survival (CNN-Survival) 
model with a modified loss function, which captures survival patterns would outperform 
conventional radiomics and CPH-based prognosis models. 
Methods 
Architecture of the proposed CNN-Survival 
A CNN architecture with six-layered convolutions (CNN-Survival) was trained as shown in Figure 
1. Input images have dimensions of 1401401 (grey scale), which contain the CT images within 
the manual contours of the tumors (example shown in Figure 2). All convolutional layers have 
kernel size of 33 with 32 filters following by Batch Normalization layers (BN). The first Max Pool 
layer has pool size of 2×2, and the latter two Max Pool layers have pool size of 3×3. Through the 
Max Pool layers, number of trainable parameters was significantly reduced. To avoid overfitting 
with this small sample size, dropout layers were added after every two convolutional layers with 
dropout rate at 0.5. Finally, passing through the flatten layer, images were converted into 800 
features where survival probabilities for a given time t were calculated. 
 Figure 1 The proposed CNN-Survival architecture: 6-layer CNN batch normalization and Max 
Pooling layers. There are also three dropout layers to control the potential overfitting.  
 
  
 
 
 
 
 
Figure 2 Example of the input CT images   
Left: NSCLC tumor from Cohort 1. Right: PDAC tumor from Cohort 2 
 
Loss Function 
To better fit the distribution of survival data, a modified loss function, proposed by Gensheimer et 
al3, was applied to the CNNs architecture (Equation 1).  
𝑙𝑜𝑠𝑠 =  − ∑ ln(ℎ𝑗
𝑖) − ∑ l n(1 − ℎ𝑗
𝑖)
𝑟𝑗
𝑖=𝑑𝑗+1
 
𝑑𝑗
𝑖=1         (1) 
In the Equation 1, ℎ𝑗
𝑖 is the hazard probability for individual i during time interval j. 𝑟 stands for 
individuals “in view” during the interval j (i.e., survived in this period) and 𝑑 means a patient 
suffered a failure (e.g., death) during this interval3. As it can be seen from Equation 1, the left part 
penalizes if the model gave low hazard for failure (e.g., death), while the right part penalizes if the 
model gave high hazard for a survived case. The overall loss function is the sum of the losses for 
each time interval3.  
Data 
CT scans along with patient outcome (survival and time to death) from three independent cohorts 
were used in this study. Cohort 1 consists of publicly available 422 Non-small cell lung cancer 
(NSCLC) patients29. Cohort 2 has 68 resectable pancreatic adenocarcinoma (PDAC) patients 
collected from a local hospital. Cohort 3, which is the test data, consists of 30 resectable PDAC 
patients enrolled in another independent hospital site21. For all the patients in these three 
independent cohorts, CT scans, annotations (contours) of tumor performed by radiologists, and 
survival data were available. For PDAC patients, the CT scans were preoperative images of 
resectable patients, and the survival data was collected from the date of surgery until death. The 
institutions’ Research Ethics Boards approved these retrospective studies and all methods were 
carried out in accordance with relevant guidelines and regulations.  
 
Training process and Transfer Learning 
Training a CNN-based survival model needs to finetune a large number of features. Given this CNN 
architecture, there were 73,587 trainable parameters. As such, the larger dataset, cohort 1, was used 
to pretrain the network. In Cohort 2, 422 patients had 5,479 slices containing manually contoured 
tumor regions. However, the region of interest (ROI) on some of the slices were too small (e.g., less 
than 200 pixels) to be fed as input to the CNN (shown in Figure 3). To mitigate this, we ranked 
slices using their ROI size and pixel intensity and picked the top 2,500 slices. This ensured the 
minimum ROI size of 250 pixels. 
 
 Figure 3 Example of small ROI in Cohort 1 
 
These 2,500 slices were fed into the proposed CNN model. After training the initial model for 50 
epochs, all the weights in the pretrained model were frozen except for the final dense layer. Next, 
68 patients from Cohort 2 were used to finetune the dense layer which contains 627 parameters. 
The finetuning was necessary since Cohort 1 and Cohort 2 have CT images from two different types 
of disease (lung and pancreas cancer, respectively) with different survival patterns. After 20 epochs 
of finetuning, the final model was tested in Cohort 3, and the concordance index at 1 year was 
calculated using Equation 2.  
c =
1
|ℰ|
  ∑ ∑ 𝟏𝐟(𝐱𝐢)<𝐟(𝐱𝐣)𝑇𝑗>𝑇𝑖Ti  uncensored     (2) 
where the indicator function 1𝑎 < 𝑏 = 1 if a < b, and 0 otherwise. 𝑇𝑖 is the survival time for subject 
i. |ℰ| is the number of edges in the order graph. f(𝑥𝑖) is the predicted survival time for subject i by 
model f. Under this formula, concordance index (CI) is the probability of concordance between 
the predicted and the observed survival30. 
 
Traditional Radiomics analytic pipeline 
To compare the prognostic performance of the proposed CNN-Survival model to traditional 
radiomic based CPH models, the following model was built. In Cohort 2 and Cohort 3, 2D 
radiomics features were extracted from the manually contoured regions using PyRadiomics 
library (version 2.0), generating 410 features in total20,21. A recent study using these two datasets 
has developed a radiomic signature that was shown to be associated with overall survival in 
resectable PDAC cohorts21. The formula of the signature is given in Equation 3. 
𝑅𝑎𝑑𝑖𝑜𝑚𝑖𝑐𝑠 𝑆𝑖𝑔𝑛𝑎𝑡𝑢𝑟𝑒 =  𝑒0.44∗𝐹1 + 0.11∗𝐹2  (3) 
where F1 is original_glcm_SumEntropy and F2 is squareroot_glcm_ClusterTendency. In this study, 
a CPH model was trained using this Radiomics Signature in Cohort 2. Then, the performance of 
this radiomics based CPH model was validated in Cohort 3 by Concordance Index using R software 
(version 3.5.3) and SurvComp library31. 
Results 
Pretraining the proposed CNN-Survival with Cohort 1, given learning rate of 0.0001, the loss 
decreased significantly with the first ten epochs where the loss of training and validation sets 
converged quickly. Concordance index (CI) was used to measure the fit of the survival function. In 
Cohort 1 (training), CNN-Survival had a CI of 0.642. After finetuning using Cohort 2, the proposed 
model achieved a CI of 0.644 in Cohort 3 (test). However, if a CNN-Survival was trained from 
scratch in Cohort 2, the CI was 0.526 in the test cohort, indicating the importance of transfer 
learning in the small sample size setting. Previous radiomics study had identified a robust radiomics 
feature based signature across two different institutions21. However, in the test cohort, using CPH, 
the Radiomics Signature yielded CI of 0.528, which was significantly lower than that of the 
proposed CNN-Survival model as shown in Table 1.  
 
Table 1: Results (concordance index) of three survival models for resectable PDAC 
 Cohort 3 (test) 
Radiomics Signature + CPH 0.528 
Proposed CNN-Survival 
(Without Transfer Learning) 
0.526 
Proposed CNN-Survival 
(With Transfer Learning) 
0.644 
 
As discussed above, CNN-Survival could depict the survival probability of a patient at a given time. 
The survival probabilities of two patients (one survived versus one deceased) in the test cohort are 
shown in Figure 4 and Figure 5.  
 
 
 Figure 4. Survival probability curve generated by the proposed CNN-Survival model for a patient 
deceased 316 days after surgery.  
 
 
Figure 5. Survival probability curve generated by the proposed CNN-Survival for a patient survived 
more than one year after surgery. 
 
 
For the patient deceased within one year after surgery, the survival probability dropped 
significantly, while for the survived patient, the survival probability stays above 0.5. 
Discussion 
Using the proposed CNN-Survival model, the prognosis performance was improved, elevating CI 
from 0.528 to 0.644. Deep learning networks provide flexibility in modifying the dimension of 
feature space and loss function, enabling us to extract disease-specific features and build more 
precise models. Using a CNN-based survival model, we showed that, with the help of transfer 
learning, deep learning architectures can outperform traditional pipeline in a typical small sample 
size setting in modeling survival for resectable PDAC patients. The proposed transfer learning-
based CNN-Survival model has significant potential. For example, we can pretrain a model using 
images from common cancers with larger datasets and transfer this model to target rare cancers. 
Transfer learning-based CNN-Survival model mitigates the needs for large sample size, allowing 
the model to be applied to a wide range of cancer sites. 
The proposed CNN-Survival model provides better performances compared to the traditional 
radiomics analytic pipeline. From the feature extraction perspective, parameters in a CNN can be 
updated during backpropagation, allowing to extract a large number of features that are associated 
with the target outcome. In contrast, given that the formula of each radiomics feature has been 
previously defined independent of outcome, some radiomics features may not be predictive for 
specific types of diseases. For feature analysis, the CNN-Survival model avoids the multiple testing, 
which is a significant issue in the conventional radiomics analytic pipeline. Finally, with the 
modified loss function, CNN-Survival model does not rely on the linear assumption, making it 
suitable for more real-world scenarios. These advantages contributed to the improved performance 
of the proposed model. In the test cohort, the proposed CNN-Survival model achieved a 
concordance index at 0.644. Although there was no prior publications reporting CI for PDAC 
patients, the CI of our proposed CNN-Survival is comparable to the typical CI for other biomedical 
survival models32. We also built a CPH model based on Radiomic Signature for resectable PDAC 
cases from a previous work21, and demonstrated that the proposed CNN-Survival model 
outperforms the traditional radiomics-based survival models.   
In this research, due to the small sample size in PDAC cohorts, the proposed CNN model was not 
optimal. We used CT images from 68 patients to finetune the pretrained CNN-Survival model and 
tested in another 30 patients of an independent cohort. Although through transfer learning, most of 
the parameters were trained using the pretrained cohort, there were still 627 parameters in the dense 
layer needed to be modified through finetuning. Thus, if a larger dataset was available for finetuning, 
performance may be further improved. Additionally, the pretrained dataset are CT images from 
Non-Small Cell Lung Cancer (NSCLC) patients. Although it is the largest open source dataset we 
could find, NSCLC has different biological traits and survival patterns compared to PDAC. In future 
research, using a similar pretrained domain and a larger finetuning cohort, further improvement 
may be achieved. 
In this study, using CT images from three independent cohorts, we validated the proposed CNN-
Survival with the modified loss function proposed by Gensheimer et al3. We showed that the 
proposed CNN-Survival model outperformed and avoided the limitations of the conventional 
radiomics-based CPH model in a real-world small sample size setting. Further validation of this 
loss function can be performed for other types of diseases through transfer learning. The proposed 
CNN-Survival model has the potential to be a standardized survival model in quantitative medical 
imaging research field.    
Conclusions 
The proposed CNN-based survival model outperforms traditional CPH-based radiomics pipeline in 
PDAC prognosis. This approach offers a better fit for survival patterns based on CT images and 
overcomes the limitations of conventional survival models. 
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